Cite
MLA Citation
J Gillmore et al.. “Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy.” European heart journal, vol. 41, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100117806663.0x00004f